257 related articles for article (PubMed ID: 8408470)
1. Bone metabolic activity measured with positron emission tomography and [18F]fluoride ion in renal osteodystrophy: correlation with bone histomorphometry.
Messa C; Goodman WG; Hoh CK; Choi Y; Nissenson AR; Salusky IB; Phelps ME; Hawkins RA
J Clin Endocrinol Metab; 1993 Oct; 77(4):949-55. PubMed ID: 8408470
[TBL] [Abstract][Full Text] [Related]
2. Assessment of porcine bone metabolism by dynamic.
Piert M; Zittel TT; Becker GA; Jahn M; Stahlschmidt A; Maier G; Machulla HJ; Bares R
J Nucl Med; 2001 Jul; 42(7):1091-100. PubMed ID: 11438633
[TBL] [Abstract][Full Text] [Related]
3. A prospective study of risedronate on regional bone metabolism and blood flow at the lumbar spine measured by 18F-fluoride positron emission tomography.
Frost ML; Cook GJ; Blake GM; Marsden PK; Benatar NA; Fogelman I
J Bone Miner Res; 2003 Dec; 18(12):2215-22. PubMed ID: 14672357
[TBL] [Abstract][Full Text] [Related]
4. Bone disease in renal failure. Clinical and histomorphometric studies.
Nilsson P
Scand J Urol Nephrol Suppl; 1984; 84():1-68. PubMed ID: 6393322
[TBL] [Abstract][Full Text] [Related]
5. Renal osteodystrophy: alpha-Heremans Schmid glycoprotein/fetuin-A, matrix GLA protein serum levels, and bone histomorphometry.
Coen G; Ballanti P; Balducci A; Grandi F; Manni M; Mantella D; Pierantozzi A; Ruggeri M; Sardella D; Sorbo G; Bonucci E
Am J Kidney Dis; 2006 Jul; 48(1):106-13. PubMed ID: 16797392
[TBL] [Abstract][Full Text] [Related]
6. Relationship between bone histology and markers of bone and mineral metabolism in African-American hemodialysis patients.
Moore C; Yee J; Malluche H; Rao DS; Monier-Faugere MC; Adams E; Daramola-Ogunwuyi O; Fehmi H; Bhat S; Osman-Malik Y
Clin J Am Soc Nephrol; 2009 Sep; 4(9):1484-1493. PubMed ID: 19713297
[TBL] [Abstract][Full Text] [Related]
7. Bone disease in patients with long-term renal transplantation and normal renal function.
Carlini RG; Rojas E; Weisinger JR; Lopez M; Martinis R; Arminio A; Bellorin-Font E
Am J Kidney Dis; 2000 Jul; 36(1):160-6. PubMed ID: 10873886
[TBL] [Abstract][Full Text] [Related]
8. Secondary hyperparathyroidism in chronic renal failure.
Malmaeus J
Scand J Urol Nephrol Suppl; 1983; 70():1-63. PubMed ID: 6351238
[TBL] [Abstract][Full Text] [Related]
9. [Long-term treatment of secondary hyperparathyroidism in the chronic hemodialysis patient with 1,25-(OH)2D3].
Giachino G; Giacchino F; Jeantet A; Del Piano A; Garetto A; Pellerey M; Piccoli G
Minerva Med; 1985 Mar; 76(9-10):407-14. PubMed ID: 2984605
[No Abstract] [Full Text] [Related]
10. Refractory renal hyperparathyroidism: clinical features and outcome of surgical therapy.
McHenry CR; Wilhelm SM; Ricanati E
Am Surg; 2001 Apr; 67(4):310-6; discussion 316-7. PubMed ID: 11307995
[TBL] [Abstract][Full Text] [Related]
11. [Management of renal osteopathy in patients with chronic dialysis].
Kiss D; Brunner FP
Schweiz Med Wochenschr; 1996 Oct; 126(42):1792-8. PubMed ID: 8966512
[TBL] [Abstract][Full Text] [Related]
12. Suppressive effect of calcium on parathyroid hormone release in adynamic renal osteodystrophy and secondary hyperparathyroidism.
Goodman WG; Veldhuis JD; Belin TR; Juppner H; Salusky IB
Kidney Int; 1997 May; 51(5):1590-5. PubMed ID: 9150477
[TBL] [Abstract][Full Text] [Related]
13. Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidism.
Ogata H; Koiwa F; Shishido K; Takahashi K; Ito H; Kinugasa E; Taguchi S
Ther Apher Dial; 2007 Jun; 11(3):202-9. PubMed ID: 17498002
[TBL] [Abstract][Full Text] [Related]
14. Can bone histomorphometry be predicted by clinical assessment and noninvasive techniques in peritoneal dialysis?
Joffe P; Heaf JG; Jensen C
Miner Electrolyte Metab; 1996; 22(4):224-33. PubMed ID: 8807626
[TBL] [Abstract][Full Text] [Related]
15. Calcitriol may directly suppress bone turnover.
Ureña P; Prieur P; Pétrover M
Nephron; 1997; 75(1):116-7. PubMed ID: 9031288
[No Abstract] [Full Text] [Related]
16. Diagnostic value of serum peptides of collagen synthesis and degradation in dialysis renal osteodystrophy.
Mazzaferro S; Pasquali M; Ballanti P; Bonucci E; Costantini S; Chicca S; De Meo S; Perruzza I; Sardella D; Taggi F
Nephrol Dial Transplant; 1995; 10(1):52-8. PubMed ID: 7724029
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of new markers of bone metabolism in renal osteodystrophy in children].
Deschenes G; Souberbielle JC; Brunelle F; Dechaux M
Ann Pediatr (Paris); 1990 Feb; 37(2):120-2. PubMed ID: 2181914
[TBL] [Abstract][Full Text] [Related]
18. Surgically induced uremia in rats. I: Effect on bone strength and metabolism.
Jablonski G; Klem KH; Attramadal A; Dahl E; Rønningen H; Gautvik KM; Haug E; Gordeladze JO
Biosci Rep; 1993 Oct; 13(5):275-87. PubMed ID: 8142613
[TBL] [Abstract][Full Text] [Related]
19. Micro-CT in the Assessment of Pediatric Renal Osteodystrophy by Bone Histomorphometry.
Pereira RC; Bischoff DS; Yamaguchi D; Salusky IB; Wesseling-Perry K
Clin J Am Soc Nephrol; 2016 Mar; 11(3):481-7. PubMed ID: 26712809
[TBL] [Abstract][Full Text] [Related]
20. Decreased mineralization in hemodialysis patients after subtotal parathyroidectomy.
Weinstein RS
Calcif Tissue Int; 1982 Jan; 34(1):16-20. PubMed ID: 6802455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
